Echinacea

botanicalEchinacea extract

What is it

Echinacea is a genus of flowering plants in the daisy family, native to North America. Three species are most commonly used in herbal medicine: Echinacea purpurea (purple coneflower, the most commercially common), E. angustifolia, and E. pallida. The roots and aerial parts contain different bioactive profiles.

How it works

Echinacea contains multiple categories of bioactive compounds: alkamides (especially in roots), polysaccharides, cichoric acid, and glycoproteins, with different species and plant parts contributing different ratios. Alkamides are thought to be primarily responsible for immune-modulating effects, interacting with cannabinoid receptors and affecting cytokine production by immune cells. Polysaccharides may stimulate macrophage and natural killer cell activity. Clinical evidence is most extensive for echinacea's use in preventing and treating upper respiratory infections (the common cold). The picture is complex because trials use different species, plant parts, extraction methods, and dose schedules, making cross-study comparisons difficult. A 2014 Cochrane Review concluded that some echinacea preparations might modestly reduce cold incidence and duration, but evidence for any single product is weak. Quality control varies dramatically, and commercial products may not contain what the label claims.

Evidence for 5 uses

AI-assisted evidence assessment — talk to your doctor before relying on any single supplement.

Upper respiratory infection (cold) treatment

Grade C

Moderate evidence

A 2014 Cochrane Review of 24 trials concluded that some echinacea preparations may modestly reduce cold duration and severity when started at symptom onset, but evidence for any single product is weak. Trials of Echinacea purpurea aerial parts (Echinaforce, others) at higher doses started early have shown small effects.

Upper respiratory infection prevention

Grade C

Moderate evidence

Meta-analyses suggest daily echinacea may modestly reduce the risk of catching a cold (relative risk reduction roughly 10 to 20 percent). Effects are smaller than influenza vaccination or hand hygiene.

Wound healing (topical)

Grade D

Mixed evidence

Traditional use includes topical application for skin wounds. Modern controlled evidence for topical echinacea is limited.

Acne

Grade D

Mixed evidence

Some studies have explored topical echinacea for acne with mixed results. Not standard recommendation.

Anxiety

Grade D

Mixed evidence

A small trial of E. angustifolia extract showed reductions in anxiety symptoms. Mechanism may involve alkamide interaction with cannabinoid receptors. Evidence is preliminary.

4 commercial forms

Echinacea purpurea aerial parts (pressed juice or extract)

High alkamide and cichoric acid content; the form in most positive cold trials (Echinaforce).

Most commonly studied. Liquid tinctures and tablets standardized to specific bioactive content.

Echinacea purpurea root extract

Different alkamide profile than aerial parts.

Common in capsules. 300 to 500 mg three times daily for acute use.

Echinacea angustifolia root extract

Higher alkamide content than purpurea; traditional Native American use.

Often considered more potent per gram. Used in research trials including some for anxiety.

Echinacea pallida root

Different bioactive profile; less commonly used commercially.

European traditional use. Less well-studied than the other two species.

Dosage

There is no standard dose. Typical preparations include: Echinacea purpurea pressed juice 6 to 9 mL/day; E. purpurea root extract 300 to 500 mg three times daily; E. angustifolia root extract 200 to 300 mg three times daily. For acute treatment of colds, doses are typically higher and taken at first symptom onset, then continued for 7 to 14 days. For prevention during cold season, lower daily doses for 2 to 6 months are used.

When and how to take it

For acute treatment of a cold, start echinacea at the very first symptom (sore throat, scratchy nose, tiredness) and continue for 7 to 14 days at the higher end of the dose range. Starting after day 2 of symptoms substantially reduces benefit. Take with or without food. For prevention during cold season, daily lower-dose use for 2 to 4 months is the typical pattern, often with periodic breaks. Liquid extracts and tinctures may have faster onset than capsules. Pair with vitamin C and zinc for combined immune support.

Safety

Echinacea is generally well tolerated. Side effects are uncommon and mild: nausea, stomach discomfort, dizziness, headache, and skin rash. Allergic reactions occur, particularly in people allergic to other Asteraceae plants (ragweed, chrysanthemums, marigolds); rare severe reactions including anaphylaxis have been reported. No formal Tolerable Upper Intake Level has been established. Long-term safety beyond 8 weeks has been less well studied; some sources suggest cycling rather than continuous use, though evidence for cycling is weak. Pregnancy and breastfeeding have limited data, though traditional and some modern use has not flagged major signals. Echinacea's immune-stimulating effects make it inappropriate for people with autoimmune diseases or on immunosuppressants.

Who should be cautious

Avoid with autoimmune diseases (lupus, RA, MS, psoriasis, Crohn's, ulcerative colitis), HIV infection (especially without antiretroviral therapy), tuberculosis, leukemia, on immunosuppressants, or post-organ transplant. Avoid with Asteraceae plant allergies. Use cautiously during pregnancy and breastfeeding. Use cautiously with hepatically metabolized medications. Children may use lower doses but data are limited.

Interactions

Echinacea may reduce the effectiveness of immunosuppressant medications (cyclosporine, tacrolimus, corticosteroids, biologics), important for transplant recipients and autoimmune disease patients. May affect CYP1A2 and CYP3A4, altering metabolism of some medications (caffeine, theophylline, certain statins, some antidepressants). May reduce effectiveness of warfarin in some cases. Otherwise generally well tolerated alongside common medications.

Frequently asked questions

Does echinacea actually prevent or shorten colds?⌄

Modestly, based on the best available evidence. A 2014 Cochrane Review concluded some echinacea preparations may shorten colds when started at symptom onset, but evidence for any specific product is weak and quality varies dramatically between brands. Effects are smaller than prevention through hand washing and vaccination.

When should I take echinacea for a cold?⌄

At the very first symptom (scratchy throat, runny nose, fatigue). Starting after symptoms are established substantially reduces benefit. Continue for 7 to 14 days.

Can I take echinacea every day during cold season?⌄

Some prevention trials use daily dosing for 2 to 6 months. Many sources recommend cycling (3 weeks on, 1 week off) without strong evidence for why. The immune-stimulating mechanism makes long-term continuous use less clear.

Is echinacea safe for kids?⌄

Children's doses are typically lower and short-term. Some trials in children have raised allergic reaction concerns more prominently than in adults. Coordinate with pediatrician.

Can I take echinacea with my autoimmune medication?⌄

No. Echinacea stimulates immune function, which is the opposite of what immunosuppressive treatment for autoimmune disease aims to do. People with lupus, RA, MS, Crohn's, ulcerative colitis, or on biologics should avoid echinacea.

References

  • Wikidata: Echinacea — Wikidata link

Track Echinacea with Pilora

Set up dose reminders, check interactions, and join the community in the Pilora iPhone app.

Coming to App Store

Disclaimer: These statements have not been evaluated by the FDA. This page is educational, not a substitute for personalized medical advice. Evidence grades are AI-assisted assessments — talk to your doctor before starting any new supplement, especially if you're pregnant, breastfeeding, on medications, or managing a chronic condition.